Shenzhen Techdow Pharmaceutical Co. Ltd
UkraineAll drugs from this manufacturer
-
The drug is used for the prevention of venous thromboembolic complications (e.g., after surgery or due to limited mobility caused by disease), for the treatment of deep vein thrombosis and pulmonary embolism, as well as in acute coronary syndrome (unstable angina and myocardial infarction).
Dosage form: solution for injection
Active substance Dosage enoxaparin sodium 100 mg/ml or 2000 anti-factor Xa IU/0.2 ml or 4000 anti-factor Xa IU/0.4 ml or 6000 anti-factor Xa IU/0.6 ml or 8000 anti-factor Xa IU/0.8 ml or 10000 anti-factor Xa IU/1.0 ml ATC: B01AB05
-
The drug is used for the prevention of blood clots (venous thromboembolic complications) in patients following surgical operations (specifically orthopedic and oncological surgeries), as well as in individuals with acute illnesses that limit mobility. It is also prescribed for the treatment of deep vein thrombosis, pulmonary embolism, and acute coronary syndrome (myocardial infarction or unstable angina).
Dosage form: solution for injection
Active substance Dosage enoxaparin sodium 300 mg ATC: B01AB05
-
The drug is used for the prevention of venous thromboembolic complications (e.g., after surgical interventions or in patients with limited mobility), for the treatment of deep vein thrombosis and pulmonary embolism, as well as in acute coronary syndrome (unstable angina and myocardial infarction). It is also used to prevent thrombus formation during hemodialysis.
Dosage form: solution for injection
Active substance Dosage enoxaparin sodium 500 mg (50 000 anti-factor Xa IU)/5 ml ATC: B01AB05